- There will be two main catalysts for the week ahead:
- Vaccine news coming early Monday with the AstraZenca/Oxford vaccine candidate
- Q2 earnings season continues with a more broad list of sector leaders
- Keep in mind last week phase one vaccine hopes had a bigger positive market impact vs financials earnings